Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Condition(s):EpilepsyLast Updated:April 11, 2019Completed
Hide Studies Not Open or Pending
Condition(s):EpilepsyLast Updated:April 11, 2019Completed
Condition(s):Neuropathy, Small FiberLast Updated:January 27, 2016Unknown status
Condition(s):Catamenial EpilepsyLast Updated:June 8, 2023Recruiting
Condition(s):EpilepsyLast Updated:August 15, 2023Completed
Condition(s):Epilepsy; Partial-onset SeizuresLast Updated:January 18, 2020Completed
Condition(s):Partial Seizures (With or Without Secondary Generalized Seizures); Primary Generalized Tonic-clonic SeizuresLast Updated:March 2, 2022Completed
Condition(s):Partial Seizures (With or Without Secondary Generalized Seizures); Primary Generalized Tonic-clonic SeizuresLast Updated:August 5, 2022Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:May 6, 2023Terminated
Condition(s):EpilepsyLast Updated:August 9, 2021Completed
Condition(s):EpilepsyLast Updated:September 7, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.